Startseite Medizin Pseudo-erythroblastosis on Sysmex XN hematology analyzers: a clue to Candida sepsis. Case report and literature review
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Pseudo-erythroblastosis on Sysmex XN hematology analyzers: a clue to Candida sepsis. Case report and literature review

  • Antonio La Gioia ORCID logo EMAIL logo , Manuela Basile , Fabiana Fiorini ORCID logo , Elisabetta Andreoli , Domenico Salamone und Marcello Fiorini ORCID logo
Veröffentlicht/Copyright: 23. Juni 2022

Received: 2022-05-19
Accepted: 2022-06-13
Published Online: 2022-06-23
Published in Print: 2022-08-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future
  4. Rethinking internal quality control: the time is now
  5. Review
  6. Multi-omics analysis from archival neonatal dried blood spots: limitations and opportunities
  7. Opinion Papers
  8. ‘Penelope test’: a practical instrument for checking appropriateness of laboratory tests
  9. Interference by macroprolactin in assays for prolactin: will the In Vitro Diagnostics Regulation lead to a solution at last?
  10. EFLM Paper
  11. Efficiency, efficacy and subjective user satisfaction of alternative laboratory report formats. An investigation on behalf of the Working Group for Postanalytical Phase (WG-POST), of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
  12. General Clinical Chemistry and Laboratory Medicine
  13. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia
  14. Repository of intra- and inter-run variations of quantitative autoantibody assays: a European multicenter study
  15. Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours
  16. Comparison of four different immunoassays and a rapid isotope-dilution liquid chromatography-tandem mass spectrometry assay for serum folate
  17. Analytical quality specifications in semen analysis according to the state of the current methodologies
  18. Reference Values and Biological Variations
  19. Short-term biological variation study of plasma hemophilia and thrombophilia parameters in a population of apparently healthy Caucasian adults
  20. First morning voided urinary gonadotropins in children: verification of method performance and establishment of reference intervals
  21. Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults
  22. Cancer Diagnostics
  23. Serum free light chain analysis: persisting limitations with new kids on the block
  24. Cardiovascular Diseases
  25. Age partitioned and continuous upper reference limits for Ortho VITROS High Sensitivity Troponin I in a healthy paediatric cohort
  26. The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions
  27. Infectious Diseases
  28. Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2
  29. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay
  30. Presepsin levels in neonatal cord blood are not influenced by maternal SARS-CoV-2 infection
  31. Letters to the Editors
  32. How to evaluate fixed clinical QC limits vs. risk-based SQC strategies
  33. Reply to Westgard et al.: ‘Keep your eyes wide … as the present now will later be past’*
  34. Platelet phagocytosis by monocytes
  35. Early detection of Candida parapsilosis in peripheral blood as a result of a peripheral blood smear performed after cytographic changes on the Beckman Coulter UniCel DxH 800 hematology
  36. Pseudo-erythroblastosis on Sysmex XN hematology analyzers: a clue to Candida sepsis. Case report and literature review
  37. Covert poisoning with difenacoum: diagnosis and follow-up difficulties
  38. Comparison of Sebia Capillarys 3-OCTA with the Tosoh Bioscience HLC®-723G8 method for A1C testing with focus on analytical interferences and variant detection
Heruntergeladen am 17.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0486/html?lang=de
Button zum nach oben scrollen